Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-22-220173
Filing Date
2022-08-15
Accepted
2022-08-12 20:00:00
Documents
1
Effectiveness Date
2022-08-15

Document Format Files

Seq Description Document Type Size
1 S-8 POS d371530ds8pos.htm S-8 POS 32404
  Complete submission text file 0001193125-22-220173.txt   33419
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-216638 | Film No.: 221161910
SIC: 2834 Pharmaceutical Preparations